Global Cancer Profiling Market Size, Share, Opportunities, And Trends By Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing, Quantitative Polymerase Chain Reaction (qPCR), Mass Spectrometry, Microarrays, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Kidney Cancer, Liver Cancer, Others), By Application (Personalized Medicine, Oncological Diagnostics, Cancer Research, Biomarker Discovery, Treatment & Monitoring, Others), And By Geography - Forecasts From 2024 To 2029

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL CANCER PROFILING MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Immunohistochemistry

5.3. In situ Hybridization

5.4. Next-Generation Sequencing

5.5. Quantitative Polymerase Chain Reaction (qPCR)

5.6. Mass Spectrometry

5.7. Microarrays

5.8. Others

6. GLOBAL CANCER PROFILING MARKET BY CANCER TYPE

6.1. Introduction

6.2. Breast Cancer

6.3. Lung Cancer

6.4. Colorectal Cancer

6.5. Prostate Cancer

6.6. Melanoma Cancer

6.7. Kidney Cancer

6.8. Liver Cancer

6.9. Others

7. GLOBAL CANCER PROFILING MARKET BY APPLICATION

7.1. Introduction

7.2. Personalized Medicine

7.3. Oncological Diagnostics

7.4. Cancer Research

7.5. Biomarker Discovery

7.6. Treatment & Monitoring

7.7. Others

8. GLOBAL CANCER PROFILING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. UK

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. South Africa

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Illumina, Inc.

10.2. Qiagen N.V.

10.3. NeoGenomics Laboratories, Inc.

10.4. F. Hoffmann-La Roche Ltd

10.5. Genomic Health

10.6. GE Healthcare

10.7. Siemens Healthineers

10.8. Thermo Fisher Scientific Inc.

10.9. Hologic Inc.

10.10. Bio-Rad Laboratories Inc